Back to search

Article

Central nervous system biomarkers GFAp and NfL associate with post-acute cognitive impairment and fatigue following critical COVID-19

2022-08-25

Abstract excerpt

<h4>Background: </h4> A high proportion of patients with coronavirus disease 2019 (COVID-19) experience post-acute COVID-19, including neuropsychiatric symptoms. Objective signs of central nervous system (CNS) damage can be investigated using CNS biomarkers such as glial fibrillary acidic protein (GFAp), neurofilament light chain (NfL) and total tau (t-tau). We have examined whether CNS biomarkers can predict fati...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1998db77-3025-551a-b06d-699ef6fe0bcf
DOI
10.21203/rs.3.rs-1959033/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Central nervous system biomarkers GFAp and NfL associate with post-acute cognitive impairment and fatigue following critical COVID-19DOI 10.21203/rs.3.rs-1959033/v1
Select a neighboring publication to make it the new centre.